19th Expert Committee on the Selection and Use of Essential Medicines: Applications (Sections 1-15)

• Sections 16-29

Section 1: Anaesthetics

• Anaesthetics (Review) -- Children

Section 2: Analgesics

• Colchicine (Re-instatement) -- Adults
• Hydromorphone (Addition) -- Children
• Morphine (New formulation) -- Children
• Naproxen (Addition) -- Adults
• Oxycodone (Addition) -- Children

Section 3: Antiallergics

• Histamine-1 receptor antagonists (Review) -- Adults and Children

Section 4: Antidotes

• Fomepizole (Addition) -- Adults and Children

Section 5: Anticonvulsants/antiepileptics

Section 6: Anti-infective medicines

• Abacavir (New formulation) -- Children
• Abacavir + lamivudine (Addition) -- Adults
• Abacavir + lamivudine (Addition) -- Children
• Amphotericin (To be moved to core list) -- Adults and Children
• Antiretrovirals (Formulations to be considered for possible deletion) -- Adults and Children
• Artesunate + mefloquine (Addition) -- Adults and Children
• Atazanavir + ritonavir (Addition) -- Adults
• Bedaquiline (Addition) -- Adults
• Benznidazole (New formulation) -- Children
• Efavirenz (New formulation) -- Children
• Efavirenz + lamivudine + tenofovir disoproxil fumarate (Addition) -- Adults
• Flucytosine (To be moved to core list) -- Adults and Children
• Isoniazid + pyridoxine + sulfamethoxazole + trimethoprim (Addition) -- Adults and Children
• Lamivudine + nevirapine + zidovudine (New formulation) -- Children
• Lamivudine + stavudine (New formulation) -- Children
• Lamivudine + tenofovir disoproxil fumarate (Addition) -- Adults
• Lamivudine + zidovudine (New formulation) -- Children
• Nevirapine (New formulation) -- Children
• Nifurtimox + eflornithine (Addition) -- Children
• Nifurtimox + eflornithine (Review) -- Adults and Children
• Oseltamivir (Deletion) -- Adults and Children
• Pegylated interferon (Addition) -- Adults
• Second-line antituberculosis medicines (Review) -- Children
• Streptomycin (To be moved to complementary list) -- Children

Section 7: Antimigraine medicines

Section 8: Antineoplastic

• Imatinib (Addition) -- Adults
• Imatinib (Addition) -- Adults and Children
• Palliative care (New section) -- Children
• Palliative care (Review) -- Adults
• Trastuzumab (Addition) -- Adults

Section 9: Antiparkinsonism medicines

• Antiparkinsonism medicines (Review) -- Adults

Section 10: Medicines affecting the blood

• Ferrous salt + folic acid (New formulation) -- Adults

Section 11: Blood products

• Colloids (Review) -- Children
• Human normal immunoglobulin (Additional dosage) -- Adults and Children
• Whole blood and red blood cells (Addition) -- Adults and Children

Section 12: Cardiovascular medicines

• Antiarrhythmics (Review) -- Children
• Fixed-dose combination for secondary prevention of cardiovascular disease (Addition) -- Adults
• Spironolactone (New indication) -- Adults
• Statins (Review) -- Children

Section 13: Dermatological medicines

• Benzoyl peroxide (Review) -- Adults and Children
• Coal tar (Review) -- Adults
• Dithranol (Deletion) -- Adults

Section 14: Diagnostic agents

Section 15: Disinfectants

• Chlorhexidine (New formulation) -- Children